National Eczema Association's Significant Grant Initiative
The National Eczema Association (NEA) has unveiled its latest grant recipients from its Research Grant program, committing $465,000 to advance the understanding and treatment of eczema. This funding will support nine exceptional researchers from various institutions in the U.S. and abroad, dedicated to exploring critical aspects of eczema, including the science behind inflammation, genetic factors, and patient perspectives.
With over two decades of commitment to eczema research, NEA has become the leading non-profit organization in this field, investing nearly $4.9 million since the inception of its grant program in 2004. This substantial financial backing has facilitated groundbreaking inquiries into the understanding of eczema's symptoms, its associated health challenges, and the quest for new treatment modalities. Wendy Smith Begolka, NEA's Chief Program Mission Officer, emphasizes that eczema affects over 31 million individuals in the U.S., significantly impacting their quality of life. The NEA's grant program was initiated to address gaps in eczema research, and its evolution over 20 years showcases the diverse array of innovative studies now being undertaken.
New Grant Categories and Their Impact
The newly awarded grants are categorized into five distinct programs:
1.
Champion Research Grant: Aimed at established researchers tackling ongoing challenges in eczema. For instance, Dr. Carlos J Aranda from the University of Granada will focus on B cell signatures in atopic dermatitis.
2.
Childhood Eczema Challenge Grant: Developed in collaboration with the Pediatric Dermatology Research Alliance (PeDRA), this grant accelerates research aimed at enhancing the health and well-being of pediatric eczema patients. Notably, Ayesha Jawed and Ernest Carter from the Kennedy Krieger Institute will work on advancing eczema screening for children with complex medical needs.
3.
Spotlight Research Grant: This promotes research centered on patient outcomes, with Dr. Joy Wan from Johns Hopkins University working on integrating patient-reported outcomes into pediatric eczema care.
4.
Catalyst Research Grant: Supporting early-career scientists in conducting hypothesis-driven projects, recipients include Dr. Mohini Bhattacharya of the University of Colorado, who will study collagen-dependent mechanisms in MRSA infections in atopic dermatitis.
5.
Engagement Research Grant: For emerging researchers piloting new concepts, Hayden Schandua from the University of California will profile anatomical endotypes in atopic dermatitis.
NEA: A Legacy of Advocacy and Support
Founded in 1988, the National Eczema Association advocates for over 31 million Americans living with eczema. NEA provides vital programs and resources that address the diverse experiences of eczema, empowering patients and caregivers to engage in their care actively. Furthermore, NEA's dedication to advancing eczema research ensures that patient voices are central in education, care, and treatment decisions.
The announcement of these grants marks a significant milestone in the ongoing fight against eczema, reinforcing the NEA's mission to improve the lives of those affected by this chronic dermatological condition. For more information on NEA’s initiatives and ongoing research support, visit
NationalEczema.org.